Pyridobenzodiazepinones, pharmaceutical compositions and method of use
thereof
    6.
    发明授权
    Pyridobenzodiazepinones, pharmaceutical compositions and method of use thereof 失效
    吡啶并二氮杂酮,药物组合物及其使用方法

    公开(公告)号:US4424222A

    公开(公告)日:1984-01-03

    申请号:US462183

    申请日:1983-01-31

    摘要: New pyridobenzodiazepinones of the formula ##STR1## are described wherein X represents oxygen, --NH-- or --NCH.sub.3 -- and R represents 1-methyl-4-piperidinyl or 4-methyl-1-piperazinyl group optionally substituted by a methyl group, or a 3.alpha.- or 3.beta.-tropanyl group, and the nontoxic pharmaceutically acceptable acid addition salts thereof. The specification also describes processes for preparing these compounds, pharmaceutical compositions containing these compounds and new intermediate products used in preparing them. The compounds of formula I have antiulcerative effects and an inhibitory effect on gastric acid secretion, without the side effects such as dryness of the mouth and mydriasis which occur with other substances having an anticholinergic activity.

    摘要翻译: 描述了式(I)的新的吡啶并苯并二氮杂酮,其中X表示氧,-NH-或-NCH 3 - ,R代表1-甲基-4-哌啶基或4-甲基-1-哌嗪基,任选被甲基取代 ,或3α-或3β-丙酰基,以及其无毒的药学上可接受的酸加成盐。 本说明书还描述了制备这些化合物的方法,含有这些化合物的药物组合物和用于制备它们的新的中间产物。 式I化合物具有抗溃疡作用和对胃酸分泌的抑制作用,而没有与具有抗胆碱能活性的其它物质发生的口腔干燥和散瞳等副作用。

    2-Phenyl-pyrimidones
    7.
    发明授权
    2-Phenyl-pyrimidones 失效
    2-苯基 - 嘧啶酮

    公开(公告)号:US4379788A

    公开(公告)日:1983-04-12

    申请号:US327348

    申请日:1981-12-04

    摘要: Compounds of the formula ##STR1## wherein A and B, together with each other and the respective carbon atoms to which they are attached, form a phenyl or pyridine ring;R.sub.1 is hydrogen, halogen, amino, nitro, alkyl of 1 to 3 carbon atoms or alkoxy of 1 to 3 carbon atoms;R.sub.2 is hydrogen or alkoxy of 1 to 3 carbon atoms;D is alkylene of 3 to 4 carbon atoms or hydroxy(alkylene of 3 to 4 carbon atoms);R.sub.3 and R.sub.5, which may be identical to or different from each other, are each hydrogen or alkyl of 1 to 3 carbon atoms;R.sub.4 is hydrogen or alkoxy of 1 to 3 carbon atoms; andR.sub.6 is straight or branched alkyl of 1 to 6 carbon atoms or --E--R.sub.7 ;where E is straight alkylene of 2 to 4 carbon atoms or hydroxy-substituted straight alkylene of 2 to 4 carbon atoms, andR.sub.7 is ##STR2## where R.sub.8 and R.sub.9 are each hydrogen, alkyl of 1 to 3 carbon atoms or alkoxy of 1 to 3 carbon atoms;and non-toxic, pharmacologically acceptable acid addition salts thereof formed with inorganic or organic acids; the compounds as well as their salts are useful as hypotensives, antiarrhythmics and .beta.-receptor-blockers.

    摘要翻译: 其中A和B与它们相连的相互连接的碳原子一起形成苯基或吡啶环; R 1是氢,卤素,氨基,硝基,1至3个碳原子的烷基或1至3个碳原子的烷氧基; R2是氢或1〜3个碳原子的烷氧基; D是3至4个碳原子的亚烷基或羟基(3至4个碳原子的亚烷基); R 3和R 5可以相同或不同,分别为氢或1-3个碳原子的烷基; R4是氢或1〜3个碳原子的烷氧基; R6是1-6个碳原子的直链或支链烷基或-E-R7; 其中E是2至4个碳原子的直链亚烷基或2至4个碳原子的羟基取代的直链亚烷基,并且R 7是R 8和R 9各自为氢,1至3个碳原子的烷基或1至 3个碳原子; 和与无机或有机酸形成的无毒的,药学上可接受的酸加成盐; 化合物及其盐可用作低血糖,抗心律失常药和β-受体阻滞剂。

    Pyridazinone-substituted benzimidazoles and salts
    8.
    发明授权
    Pyridazinone-substituted benzimidazoles and salts 失效
    哒嗪酮取代的苯并咪唑和盐

    公开(公告)号:US4361563A

    公开(公告)日:1982-11-30

    申请号:US259537

    申请日:1981-05-01

    摘要: Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen; trifluoromethyl; alkyl of 1 to 11 carbon atoms; cycloalkyl of 3 to 7 carbon atoms; hydroxyl; alkoxy of 1 to 6 carbon atoms; mercapto; (alkyl of 1 to 6 carbon atoms)-mercapto; phenyl-(alkyl of 1 to 3 carbon atoms); phenyl; or mono-, di- or tri-substituted phenyl, where the substituents, which may be identical to or different from each other, are each halogen, alkyl of 1 to 4 carbon atoms, (alkyl of 1 to 6 carbon atoms)-sulfinyl, hydroxyl, alkoxy of 1 to 6 carbon atoms, mercapto or (alkyl of 1 to 6 carbon atoms)-mercapto;R.sub.2 is hydrogen, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or phenyl-(alkyl of 1 to 3 carbon atoms); andR.sub.3 is alkyl of 1 to 6 carbon atoms; optically active antipodes thereof; and non-toxic, pharmaceutically acceptable acid addition salts of said compounds or of said optically active antiposed. The compounds are useful as cardiotonics and antithrombotics.

    摘要翻译: 其中R 1是氢的式IMAMA的化合物; 三氟甲基 1至11个碳原子的烷基; 3至7个碳原子的环烷基; 羟; 1至6个碳原子的烷氧基; 巯基 (1-6个碳原子的烷基) - 巯基; 苯基 - (1至3个碳原子的烷基); 苯基; 或单取代,二取代或三取代的苯基,其中可以相同或不同的取代基各自为卤素,具有1至4个碳原子的烷基,(1至6个碳原子的烷基) - 亚磺酰基 ,羟基,1至6个碳原子的烷氧基,巯基或(1至6个碳原子的烷基) - 巯基; R2是氢,1至6个碳原子的烷基,3至6个碳原子的环烷基或苯基 - (1至3个碳原子的烷基); 且R 3为1至6个碳原子的烷基; 光学活性对映体; 和所述化合物或所述光学活性药物的无毒的药学上可接受的酸加成盐。 这些化合物可用作强心剂和抗血栓药物。

    (Aminoalkoxy-aryl)-substituted isoquinolinones and naphthydrinones and
salts thereof, and hypotensive compositions and methods employing them
    9.
    发明授权
    (Aminoalkoxy-aryl)-substituted isoquinolinones and naphthydrinones and salts thereof, and hypotensive compositions and methods employing them 失效
    (氨基烷氧基 - 芳基) - 取代的异喹啉酮和萘啶酮及其盐,以及使用它们的低血压组合物和方法

    公开(公告)号:US4154837A

    公开(公告)日:1979-05-15

    申请号:US867308

    申请日:1978-01-06

    CPC分类号: C07D471/04 C07D217/24

    摘要: Compounds of the formula ##STR1## wherein A is benzo, mono-, di- or tri-substituted benzo, the substituents being selected from the group consisting of lower alkoxy, amino and nitro, or pyrido;R.sub.1 is hydrogen or lower alkyl;R.sub.2 is alkyl of 1 to 6 carbon atoms or --X--R.sub.6, where X is straight alkylene of 1 to 4 carbon atoms or hydroxy-substituted straight alkylene of 1 to 4 carbon atoms; andR.sub.6 is amino; carbalkoxy of 2 to 6 carbon atoms; phenyl; mono-, di- or tri-substituted phenyl, the substituents being selected from the group consisting of lower alkyl and lower alkoxy; phenoxy; or mono-, di- or tri-substituted phenoxy, the substituents being selected from the group consisting of lower alkyl and lower alkoxy;R.sub.3 is hydrogen or hydroxyl;R.sub.4 is hydrogen, lower alkyl or lower alkoxy;R.sub.5 is hydrogen or lower alkyl; andN is 0, 1 or 2;And non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful as antiarrhythmics, .beta.-adrenergic-receptor blockers and anti-anginous agents.

    摘要翻译: 其中A是苯并,一或二取代或三取代的苯并,其取代基选自低级烷氧基,氨基和硝基,或吡啶并。 R1是氢或低级烷基; R2是1至6个碳原子的烷基或-X-R6,其中X是1至4个碳原子的直链亚烷基或1至4个碳原子的羟基取代的直链亚烷基; R6为氨基; 2至6个碳原子的烷氧基; 苯基; 单取代,二取代或三取代的苯基,所述取代基选自低级烷基和低级烷氧基; 苯氧基 或单 - ,二 - 或三 - 取代的苯氧基,所述取代基选自低级烷基和低级烷氧基; R3是氢或羟基; R4是氢,低级烷基或低级烷氧基; R5是氢或低级烷基; 和N IS 0,1或2; 和非毒性,药理学上可接受的酸添加量。 化合物和盐可用作抗心律失常药,β-肾上腺素能受体阻断剂和抗麻痹剂。

    1,3-Dioxo-2-aminoalkyl-4,4-dimethyl-isoquinolines and salts thereof
    10.
    发明授权
    1,3-Dioxo-2-aminoalkyl-4,4-dimethyl-isoquinolines and salts thereof 失效
    1,3-二氧代-2-氨基烷基-4,4-二甲基 - 异喹啉及其盐

    公开(公告)号:US3948898A

    公开(公告)日:1976-04-06

    申请号:US503072

    申请日:1974-09-04

    CPC分类号: C07D217/24 Y10S514/821

    摘要: Compounds of the formula ##SPC1##Wherein R.sub.1 is hydrogen, halogen, methoxy or methylthioR.sub.2 is hydrogen or methoxy,n is 2 or 3, andA is ##SPC2##Or ##SPC3##Where R.sub.3 is hydrogen or methyl,R.sub.4 is pyridyl, methy-pyridyl, phenyl, chlorophenyl, trifluoromethyl-phenyl, tolyl, xylyl, ethyl-phenyl, diethyl-phenyl, methoxy-phenyl or dimethoxy-phenyl, andR.sub.5 and R.sub.6, which may be identical to or different from each other, are each hydrogen or methoxy,And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as the salts are useful as hypotensives, sedatives, antiarrhythmics and bradycardiacs.

    摘要翻译: 式WHEREIN R 1是氢,卤素,甲氧基或甲硫基R 2的化合物是氢或甲氧基,N IS 2 OR 3,A是或R 3是氢或甲基,R 4是吡啶基,甲基 - 吡啶基,苯基,氯苯基,三氟甲基 苯基,甲苯基,二甲苯基,乙基 - 苯基,二乙基 - 苯基,甲氧基 - 苯基或二甲氧基 - 苯基,以及可以相同或不同的R5和R6各自为氢或甲氧基。非 - 药理学上可接受的酸添加剂; 该化合物作为盐类有效地用作高血压药物,消炎药,抗精神病药和溴氰菊酯。